Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis
- 31 August 2009
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 31 (8), 1641-1651
- https://doi.org/10.1016/j.clinthera.2009.08.011
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient educationPatient Education and Counseling, 2007
- Road Maps to Achieve Glycemic Control in Type 2 Diabetes MellitusEndocrine Practice, 2007
- Using Continuous Glucose Monitoring to Measure the Frequency of Low Glucose Values When Using Biphasic Insulin Aspart 30 Compared With Biphasic Human Insulin 30Diabetes Care, 2007
- Biphasic Insulin Aspart in Type??2??Diabetes MellitusClinical Drug Investigation, 2007
- Premixed insulin treatment for type 2 diabetes: analogue or human?Diabetes, Obesity and Metabolism, 2006
- Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2006
- Efficacy of biphasic insulin aspart in patients with type 2 diabetesClinical Therapeutics, 2005
- Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetesEuropean Journal of Internal Medicine, 2004
- Improved Postprandial Glycemic Control With Biphasic Insulin Aspart Relative to Biphasic Insulin Lispro and Biphasic Human Insulin in Patients With Type 2 DiabetesDiabetes Care, 2002
- Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: A double-blind crossover study in adults with type 2 diabetes mellitusClinical Therapeutics, 2002